Close Menu

NEW YORK (360Dx) – The Foundation for Innovative New Diagnostics and the World Hepatitis Alliance announced today that the two organizations will collaborate on advocacy and communication efforts in support of hepatitis C diagnostics.

Chronic hepatitis C infection can lead to liver damage, cirrhosis, and liver cancer. Worldwide, more than 71 million people are chronically infected, and approximately 80 percent live in low- and middle-income countries with only 1 in 5 people aware they are infected.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.